3.6.1.8	15-desoxybludein	0.065 mg/ml, 11% inhibition	132697	
3.6.1.8	AMP	slight inhibition	30	
3.6.1.8	Caffeine	25% inhibition at 3 mM	882	
3.6.1.8	cAMP	20% inhibition at 3 mM	268	
3.6.1.8	eremantolide C	0.065 mg/ml, 17% inhibition	132698	
3.6.1.8	glaucolide A	0.065 mg/ml, 11% inhibition	132692	
3.6.1.8	glaucolide B	0.065 mg/ml, 16% inhibition	132693	
3.6.1.8	GMP	competitive inhibition with Ki: 0.001 mM	162	
3.6.1.8	goyazensolide	0.065 mg/ml, 10% inhibition	132695	
3.6.1.8	isogoyazensolide	0.065 mg/ml, 11% inhibition	132696